IUPUI said Monday it is cleaning and sanitizing University Tower to house health care workers, but no plans have been announced locally for temporary field hospitals.
Just like the pandemic that is sweeping the world, news about COVID-19 is developing almost too quickly to comprehend.
Indiana has been undergoing a huge shift in psychiatric care in recent years, but still doesn’t have the resources to deal with patients suffering from ailments ranging from anxiety to schizophrenia.
The grants ranged in size from $6,000 to $14.47 million and covered almost every aspect of medicine from neurology and psychiatry to anesthesiology and emergency care.
The report, issued Monday by researchers at the Fairbanks School of Public Health at IUPUI, is the latest commentary on Indiana’s poor report card on health care.
The Indianapolis drugmaker quietly terminated a collaboration with NextCure Inc. after spending $40 million on an up-front fee and equity investment, and with little to show from the partnership.
After raking in record amounts of venture capital funding in 2017 and 2018, Indiana life science companies saw funding drop last year by double-digits, while the average deal amount dipped sharply as well.
A bill that tries to address surprise out-of-network fees was among several health care-related measures proposed Monday by Indiana lawmakers during the first day of the General Assembly.
The year didn’t feature any hostile takeovers or huge disasters. But a lot of companies made big strides in 2019, including Eli Lilly and Co., Corteva and Elanco. And many rejoiced when Washington ended a 2.3% tax on thousands of medical devices.
The repeal ends a 2.3% tax on thousands of medical devices, from stents and catheters to pacemakers and MRI machines. Indiana is home to 155 device-makers, ranging from small metal shops to multibillion-dollar manufacturers.